removed 775,284 shares (-63.6%) from their portfolio in Q3 2025, for an estimated $5,264,178 CITADEL ADVISORS LLC added 657,824 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,466,624 MORGAN STANLEY removed 617,525 shares (-38.8%) from their portfolio in Q3 2025, for an estimated $4,192,994 RENAISSANCE TECHNOLOGIES LLC added 547,625 shares (+50.4%) to their portfolio in Q3 2025, for an estimated $3,718,373 JUMP FINANCIAL, LLC removed 467,652 shares (-90.8%) from their portfolio in Q3 2025, for an estimated $3,175,357 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 434,937 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,953,222 To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard
XT: Writing original draft
Patients typically self-administer these subcutaneous injections once weekly (semaglutide) or once daily (liraglutide), with doses gradually increased over several weeks to minimise gastrointestinal side effects
Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives
H tr ngn nga lo ha da sm, b sung Collagen gip tng n hi cho da
Foods 13, 4028
